What does CUSIP 28617K101 represent in this 13F holders report?

CUSIP 28617K101 is the security identifier for ELDN - Eledon Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ELDN - Eledon Pharmaceuticals, Inc. - Common Stock in Q3 2023?

28 institutional investors reported ELDN - Eledon Pharmaceuticals, Inc. - Common Stock for Q3 2023. Use the holders table for investor-level position and value details.

Eledon Pharmaceuticals, Inc. - Common Stock (ELDN)

CUSIP: 28617K101

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / Common Stock
Total 13F shares: 8,917,722
Total 13F value: $12,217,005
Share change: -135,648
SEC-reported price per share: $1.37
Number of holders: 28
Value change: -$186,914
Number of buys: 11
Number of sells: 16
Shares outstanding: 81,270,267

Security key

28617K101

Report period

Q3 2023

Institutions

Top holders

ELDN full security history Ownership snapshot Full 13F holder table Eledon Pharmaceuticals, Inc. SEC filings Eledon Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ELDN - Eledon Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BVF INC/IL

Disclosed value leader

BVF INC/IL

Comparable rows

0/15

Latest evidence

30 Jun 2023

13F 3/4/5 Highest disclosed value: $5,927,593 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BVF INC/IL has the largest disclosed position value at $5.93M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BVF INC/IL's linked filing trail.

Disclosed position value Top 5

BVF INC/IL $5.93M

ARMISTICE CAPITAL, LLC $2.52M

VANGUARD GROUP INC $931K

Woodline Partners LP $707.8K

Gary A. Lyons $674K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BVF INC/IL	13F Company 13F	— denominator unverified	$5,927,593 4,326,710 shares	—	30 Jun 2023
ARMISTICE CAPITAL, LLC	13F Company 13F	— denominator unverified	$2,524,640 1,842,803 shares	—	30 Jun 2023
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$930,993 679,557 shares	—	30 Jun 2023
Woodline Partners LP	13F Company 13F	— denominator unverified	$707,845 516,675 shares	—	30 Jun 2023
Gary A. Lyons	3/4/5 Director 3/4/5	— denominator unverified	$673,958 150,437 shares	—	01 May 2023
Ensign Peak Advisors, Inc	13F Company 13F	— denominator unverified	$606,911 443,001 shares	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

8,917,722

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

-4

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %